Table 1 Demographic data of the multidrug-resistant tuberculosis patients with or without pyrazinamide (PZA) resistancea
From: Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan
| Â | PZA susceptibility test | P value | |
|---|---|---|---|
| Â | Resistant, n = 36 | Susceptible, n = 30 | Â |
Age (MD) | 58.3 (21.0) | 57.8 (17.8) | 0.91 |
Gender | Â | Â | Â |
   Male | 25 (69.4%) | 24 (80%) | 0.33 |
   Female | 11 (30.6%) | 6 (20%) |  |
Previous anti-TB treatment | Â | Â | Â |
   Yes | 11 (30.6%) | 10 (33.3%) | 0.81 |
   No | 25 (69.4%) | 20 (66.7%) |  |
Sputum smear | Â | Â | Â |
   Positive | 17 (47.2%) | 22 (73.3%) | 0.032 |
   Negative | 19 (52.8%) | 8 (26.7%) |  |
Disease site | Â | Â | Â |
   Pulmonary TB | 35 (97.2%) | 28 (93.3%) | 0.45 |
   Extrapulmonary TB | 1 (2.8%) | 2 (6.7%) |  |
Presence of cavity in radiogram | Â | Â | Â |
   Yes | 8 (22.2%) | 12 (40%) | 0.12 |
   No | 28 (77.8%) | 18 (60%) |  |
Ethambutol resistance | Â | Â | Â |
   Yes | 21 (58.3%) | 10 (33.3%) | 0.043 |
   No | 15 (41.7%) | 20 (66.7%) |  |
Streptomycin resistance | Â | Â | Â |
   Yes | 24 (66.7%) | 11 (36.7%) | 0.015 |
   No | 12 (33.3%) | 19 (63.3%) |  |
Genotyping | Â | Â | Â |
   Beijing strain | 21 (58.3%) | 16 (53.3%) | 0.68 |
   Non-Beijing strain | 15 (41.7%) | 14 (46.7%) |  |